NCT05489965

Brief Summary

To perform a multi-site prospective study assessing, both subjectively and objectively, the gender disparities in speech outcomes of patients using TEP after total laryngectomy. The investigators hypothesize that speech outcomes, both subjective and objective measures, will be significantly poorer for female patients compared to male patients. The outcome of the study is to prospectively assess both subjective and objective gender disparities in voice and speech outcomes of patients using TEP after total laryngectomy across a multiple institutions. The investigators hypothesize that both subjective and objective measurements of voice, speech and quality of life will be poorer for female patients in comparison to male patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
1mo left

Started May 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
May 2023Jun 2026

First Submitted

Initial submission to the registry

July 28, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 5, 2022

Completed
10 months until next milestone

Study Start

First participant enrolled

May 31, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

February 11, 2026

Status Verified

February 1, 2026

Enrollment Period

3 years

First QC Date

July 28, 2022

Last Update Submit

February 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • FACT-H&N (Functional Assessment of Cancer Therapy - Head & Neck)

    Patient reported survey.

    Through study completion; 3 years (anticipate completion by June 2025)

  • AVHI (Alaryngeal Voice Handicap Index)

    Patient reported survey.

    Through study completion; 3 years (anticipate completion by June 2025)

Secondary Outcomes (3)

  • GRBAS - Grade, Roughness, Breathiness, Asthenia, and Strain

    Through study completion; 3 years (anticipate completion by June 2025)

  • Sustained phonation time

    Through study completion; 3 years (anticipate completion by June 2025)

  • Fundamental frequency

    Through study completion; 3 years (anticipate completion by June 2025)

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility Detailsthis trial is studying the disparities amongst genders (male vs. female)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients with advanced laryngeal cancer who have completed total laryngectomy requiring use of alternative methods to produce voice along with extensive speech rehabilitation.

You may qualify if:

  • Male and female subjects who have completed total laryngectomy and are using TEP

You may not qualify if:

  • Subjects who have not completed total laryngectomy and are not using TEP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Diego

La Jolla, California, 92093, United States

RECRUITING

MeSH Terms

Conditions

Speech Disorders

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2022

First Posted

August 5, 2022

Study Start

May 31, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 11, 2026

Record last verified: 2026-02

Locations